Simulations Plus, Inc. is a developer of drug discovery and development software for mechanistic modeling and simulation, for machine-learning-based prediction of properties of molecules solely from their structure, and is exploring the application of its machine-learning technologies in other industries, including aerospace/military and general healthcare. The Company provides specific proprietary software products, such as GastroPlus, a physiologically-based simulation tool that predicts the absorption, pharmacokinetics, pharmacodynamics, and drug-drug interactions for compounds administered through intravenous, oral, ocular, or pulmonary routes; ADMET Predictor, an ADME-Tox property prediction, and model building application; MedChem Studio, a multi-purpose cheminformatics platform used for advanced data mining and de novo molecule design; DDDPlus, a simulation program for formulation scientists that predicts the in vitro disintegration and dissolution of solid dosage forms under different experimental conditions; MedChem Designer, a free chemical sketching product that combines innovative molecule drawing features with fast and accurate ADMET property predictions from ADMET Predictor.
Type | Public | |
Founded | 1996 | |
HQ | Lancaster, CA, US | Map |
Website | simulations-plus.com | |
Employee Ratings | ||
Overall Culture | A | More |
USD | |
---|---|
Revenue (Q3, 2021) | 12.8m |
Gross profit (Q3, 2021) | 10.3m |
Gross profit margin (Q3, 2021), % | 80.7% |
Net income (Q3, 2021) | 3.8m |
EBIT (Q3, 2021) | 4.5m |
Market capitalization (27-May-2022) | 983.2m |
Closing stock price (27-May-2022) | 48.8 |
Cash (31-May-2021) | 58.8m |
EV | 925.8m |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.2m | 2.8m | 2.8m | 2.3m | 3.1m | 2.6m | 3.1m | 3.7m | 4.1m | 4.6m | 5.9m | 4.8m | 5.2m | 6.0m | 5.4m | 5.7m | 6.7m | 7.1m | 7.4m | 8.6m | 7.5m | 8.5m | 9.9m | 9.4m | 10.3m | 12.3m | 10.7m | 13.1m | 12.8m |
Cost of goods sold | 352.4k | 396.6k | 437.7k | 386.9k | 451.9k | 448.4k | 492.2k | 227.6k | 997.7k | 1.1m | 1.1m | 1.1m | 1.3m | 1.2m | 1.3m | 1.6m | 1.4m | 1.7m | 2.1m | 2.0m | 2.2m | 2.2m | 2.3m | 2.6m | 2.7m | 2.7m | 2.4m | 2.9m | 2.5m |
Gross profit | 1.9m | 2.4m | 2.3m | 1.9m | 2.6m | 2.2m | 2.6m | 3.5m | 3.1m | 3.4m | 4.8m | 3.8m | 3.9m | 4.8m | 4.1m | 4.2m | 5.3m | 5.3m | 5.2m | 6.5m | 5.3m | 6.3m | 7.6m | 6.8m | 7.7m | 9.6m | 8.3m | 10.2m | 10.3m |
Gross profit Margin, % | 84% | 86% | 84% | 83% | 85% | 83% | 84% | 94% | 76% | 75% | 81% | 78% | 76% | 80% | 75% | 73% | 79% | 75% | 71% | 76% | 71% | 74% | 77% | 72% | 74% | 78% | 77% | 78% | 81% |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 12.7m | 13.2m | 12.9m | 11.4m | 10.0m | 10.6m | 9.7m | 7.8m | 5.8m | 6.1m | 6.4m | 7.2m | 7.1m | 7.3m | 8.8m | 7.4m | 8.2m | 7.0m | 6.9m | 7.2m | 9.4m | 9.9m | 10.3m | 12.6m | 12.2m | 7.4m | 27.7m | 42.4m | 58.8m |
Accounts Receivable | 1.2m | 2.2m | 2.2m | 1.7m | 2.9m | 1.9m | 2.7m | 3.2m | 3.0m | 3.2m | 4.0m | 4.0m | 3.8m | 4.6m | 3.4m | 4.7m | 5.0m | 5.2m | 6.0m | 7.7m | 5.3m | 6.2m | 7.7m | 6.4m | 7.2m | 10.9m | 7.3m | 11.3m | 13.0m |
Prepaid Expenses | 106.8k | 140.4k | 113.5k | 115.8k | 137.6k | 173.1k | 177.5k | 119.2k | 264.1k | 268.8k | 269.8k | 263.1k | 309.2k | 288.2k | 314.7k | 296.4k | 304.4k | 348.7k | 436.7k | 383.7k | 502.1k | 518.5k | 533.8k | 561.1k | 612.5k | 745.5k | 1.7m | 1.4m | 1.6m |
Current Assets | 14.6m | 16.2m | 15.8m | 13.8m | 13.4m | 13.1m | 13.3m | 12.4m | 10.7m | 10.7m | 11.8m | 12.4m | 12.5m | 13.6m | 13.6m | 14.0m | 14.9m | 14.0m | 15.3m | 17.3m | 17.4m | 18.9m | 21.3m | 23.1m | 24.7m | 22.2m | 131.2m | 135.6m | 138.7m |
USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|---|---|---|---|---|
Net Income | 3.0m | 2.9m | 3.0m | 3.8m | 5.0m | 5.8m | 8.9m | 8.6m | 9.3m |
Depreciation and Amortization | 41.8k | 50.1k | 229.7k | 966.5k | 951.3k | 1.0m | 2.7m | 2.8m | 3.0m |
Accounts Payable | 1.4k | (31.5k) | (15.5k) | 19.4k | (101.3k) | 99.3k | 110.7k | (147.5k) | 220.6k |
Cash From Operating Activities | 3.8m | 2.6m | 5.3m | 7.1m | 5.4m | 6.9m | 9.3m | 11.6m | 10.9m |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 971.0k | 1.8m | 2.7m | 587.0k | 2.6m | 685.2k | 1.5m | 2.8m | 528.9k | 1.5m | 3.4m | 1.1m | 2.3m | 4.2m | 1.4m | 2.6m | 4.6m | 1.7m | 5.2m | 7.6m | 1.5m | 3.6m | 6.5m | 2.1m | 4.2m | 7.1m | 2.5m | 5.7m | 9.5m |
Depreciation and Amortization | 9.0k | 19.6k | 30.4k | 10.7k | 31.4k | 13.8k | 27.6k | 66.4k | 244.9k | 416.2k | 734.8k | 239.0k | 476.5k | 714.7k | 231.5k | 459.1k | 682.6k | 353.2k | 1.3m | 2.0m | 694.8k | 1.4m | 2.1m | 670.7k | 1.3m | 2.1m | 865.0k | 1.8m | 2.7m |
Accounts Payable | 138.3k | 211.7k | 125.3k | 16.6k | 44.2k | 89.4k | 160.7k | 31.3k | (36.8k) | (69.3k) | (56.8k) | (119.3k) | (83.3k) | (24.4k) | 103.7k | 113.2k | 103.5k | (99.1k) | (76.0k) | (43.8k) | (133.5k) | (61.9k) | (142.5k) | 380.9k | 420.6k | 324.4k | (15.0k) | 51.0k | (51.0k) |
Cash From Operating Activities | 790.0k | 1.5m | 2.9m | (261.6k) | 1.6m | 1.4m | 1.7m | 3.3m | 226.8k | 1.8m | 3.9m | (360.1k) | 652.4k | 2.7m | 1.9m | 1.7m | 4.8m | 2.6m | 4.1m | 5.8m | 2.6m | 5.7m | 7.5m | 2.6m | 3.8m | 6.1m | 5.3m | 6.6m | 10.9m |
USD | Q1, 2012 |
---|---|
Financial Leverage | 1.1 x |
2.7k
Tweets
662
Following
788
Followers
43
Tweets last 30 days
1
Avg. likes per Tweet
76.7%
Tweets with engagement
A
89/100
A+
90/100
A+
100/100
When was Simulations Plus founded?
Simulations Plus was founded in 1996.
Who are Simulations Plus key executives?
Simulations Plus's key executives are Jill Fiedler-Kelly, Brett Howell and Walter S Woltosz.
How many employees does Simulations Plus have?
Simulations Plus has 107 employees.
What is Simulations Plus revenue?
Latest Simulations Plus annual revenue is $41.6 m.
What is Simulations Plus revenue per employee?
Latest Simulations Plus revenue per employee is $388.7 k.
Who are Simulations Plus competitors?
Competitors of Simulations Plus include Schrodinger, MedCognition and Aegate.
Where is Simulations Plus headquarters?
Simulations Plus headquarters is located at 42505 10th St W, Lancaster.
Where are Simulations Plus offices?
Simulations Plus has offices in Lancaster and Buffalo.
How many offices does Simulations Plus have?
Simulations Plus has 2 offices.
Receive alerts for 300+ data fields across thousands of companies